Phenotypes of patients with APC gene mutations identified via multi-gene cancer panel testing

Date:
Sunday, Oct 2, 2016 11:00am – 12:00pm
Conference:
CGA-IGC 2016
Authors:
Amal Yussuf, Carin Espenschied, Emily Dalton, Tara Namey
  • 7.1% of APC+ patients did not meet current NCCN APC testing guidelines.
  • 54.2% of APC+ patients presented with fewer than 100 polyps suggesting that mutation carriers identified on MGPT may be more likely to present with AFAP.
  • 13% of APC mutation carriers with clinical data available had a breast cancer diagnosis, including 2 male breast cancers.